The impact of baseline liver histology on virologic response to interferon-α2b+/-ρribavirin therapy in patients with chronic hepatitis C.

被引：0
|
作者：
Fang, JS
Goodman, ZD
Albrecht, JK
Yao, R
Garaud, JJ
Lau, JN
机构：
[1] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA
[2] Armed Forces Inst Pathol, Washington, DC 20306 USA
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
572
引用
收藏
页码：303A / 303A
页数：1
相关论文
共 50 条
  • [21] Treatment with ribavirin and interferon-α reduces interferon-γ expression in patients with chronic hepatitis C
    Bergamini, A
    Bolacchi, F
    Cepparulo, M
    Demin, F
    Uccella, I
    Bongiovanni, B
    Ombres, D
    Angelico, F
    Liuti, A
    Hurtova, M
    Francioso, S
    Carvelli, C
    Cerasari, G
    Angelico, M
    Rocchi, G
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 123 (03): : 459 - 464
  • [22] Stainable hepatic iron predicts end of treatment virologic response to interferon and ribavirin therapy among patients with hepatitis C.
    Schwartz, J
    Fishman, V
    Thomas, R
    Wolfson, M
    Gaughan, J
    Kowdley, KV
    Black, M
    HEPATOLOGY, 2001, 34 (04) : 602A - 602A
  • [23] Ribavirin enhances interferon-γ levels in patients with chronic hepatitis C treated with interferon-α
    Fang, SH
    Lai, MY
    Hwang, LH
    Yang, PM
    Chen, PJ
    Chiang, BL
    Chen, DS
    JOURNAL OF BIOMEDICAL SCIENCE, 2001, 8 (06) : 484 - 491
  • [24] Serum biomarkers for monitoring pegylated interferon-α plus ribavirin therapy response in chronic hepatitis C patients
    Godinho Menezes, E.
    Coelho-Dos-Reis, J. G.
    Melo Cardoso, L.
    Dias Cambraia, R.
    Diniz Silva, L.
    Peruhype-Magalhaes, V.
    Teixeira-Carvalho, A.
    Martins Filho, O.
    Teixeira, R.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 28 - 29
  • [25] Baseline serum alanine aminotransferase as a predictor of virologic response to interferon therapy in chronic hepatitis C patients.
    Patel, K
    Tong, M
    Pockros, PJ
    McHutchison, JG
    Blatt, LM
    HEPATOLOGY, 2002, 36 (04) : 599A - 599A
  • [26] Interferon-α 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation:: A randomized study
    Samuel, D
    Bizollon, T
    Feray, C
    Roche, B
    Ahmed, SNS
    Lemonnier, C
    Cohard, M
    Reynes, M
    Chevallier, M
    Ducerf, C
    Baulieux, J
    Geffner, M
    Albrecht, JK
    Bismuth, H
    Trepo, C
    GASTROENTEROLOGY, 2003, 124 (03) : 642 - 650
  • [27] Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C
    Poynard, T
    McHutchison, J
    Davis, GL
    Esteban-Mur, R
    Goodman, Z
    Bedossa, P
    Albrecht, J
    HEPATOLOGY, 2000, 32 (05) : 1131 - 1137
  • [28] Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C
    Poynard, T
    McHutchison, J
    Manns, M
    Trepo, C
    Lindsay, K
    Goodman, Z
    Ling, MH
    Albrecht, J
    GASTROENTEROLOGY, 2002, 122 (05) : 1303 - 1313
  • [29] A prospective study of neuropsychiatric symptoms associated with interferon-α-2b and ribavirin therapy for patients with chronic hepatitis C
    Dieperink, E
    Ho, SB
    Thuras, P
    Willenbring, ML
    PSYCHOSOMATICS, 2003, 44 (02) : 104 - 112
  • [30] Factors associated with virologic response in triple therapy with simeprevir, pegylated interferon and ribavirin in Japanese patients with chronic hepatitis C
    Oze, Tsugiko
    Hiramatsu, Naoki
    Yakushijin, Takayuki
    Yamada, Ryoko
    Harada, Naoki
    Morishita, Naoki
    Tahata, Yuki
    Hikita, Hayato
    Sakamori, Ryotaro
    Miyagi, Takuya
    Yoshida, Yuichi
    Tatsumi, Tomohide
    Yamada, Akira
    Oshita, Masahide
    Hagiwara, Hideki
    Mita, Eiji
    Ito, Toshifumi
    Yamada, Yukinori
    Hijioka, Taizo
    Tamura, Shinji
    Katayama, Kazuhiro
    Yoshihara, Harumasa
    Imai, Yasuharu
    Kato, Michio
    Hayashi, Norio
    Takehara, Tetsuo
    HEPATOLOGY, 2014, 60 : 702A - 702A
12345